A PHP Error was encountered

Severity: Warning

Message: opendir(/opt/alt/php74/var/lib/php/session): failed to open dir: Permission denied

Filename: drivers/Session_files_driver.php

Line Number: 364

Backtrace:

File: /home4/aagamico/public_html/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Cannot send session cache limiter - headers already sent (output started at /home4/aagamico/public_html/system/core/Exceptions.php:271)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home4/aagamico/public_html/index.php
Line: 315
Function: require_once

April 2015-Global Lifesciences Business in India - News & Updates

April 2015-Global Lifesciences Business in India - News & Updates

In this newsletter, we bring something new. We removed hyperlinks for better deliverability in your inbox. If you like this change, please email us and let know.

Top Highlights for April 2015: 

  1. India's Sun Pharma seeking acquisitions in the U.S, Europe; may spend USD 7 Bn
  2. GIC, SG invests USD 187 Mn while sister entity Temasek invests USD 298 million in Sun Pharma
  3. India based Caplin Point receive milestone payments for licensing agreements with Fresenius Kabi USA, and Cycle Pharma, UK
  4. Temasek, Singapore to invest USD 151 Mn in India's Glenmark Pharma
  5. India based Cipla to acquire Brazilian firm Duomed Produtos Farmaceuticos for INR 2.6 Crore
  6. Aurobindo Pharma to focus on US, EU; sells its Australian arm
  7. California based Taxus Cardium announces exclusive licensing agreement with Dr. Reddy's Laboratories, India
  8. Japan's Tosoh Corporation acquires Indian Medical devices company, Lilac Medicare

For more such news and updates on please join our Group "Global Life Science Business in India" on LinkedIn.